Search clinical trials for: High-dose progesterone
Total 1051 results
-
Northwestern UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
University of VirginiaEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingPolycystic Ovary Syndrome | Hyperandrogenism | PubertyUnited States
-
Amsterdam UMC, location VUmcRecruitingGlioblastoma | Glioblastoma Multiforme | GBM | Glioblastoma, Adult | Recurrent Brain TumorNetherlands
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingBRCA1 Gene Mutation | BRCA2 Gene Mutation | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | MLH1 Gene Mutation | RAD51C Gene Mutation | RAD51D Gene Mutation | BRIP1 Gene Mutation | PALB2 Gene Mutation | BARD1 Gene Mutation | MSH2 Gene Mutation | MSH6... and other conditionsUnited States
-
Babbette LamarcaRecruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingInvasive Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | HER2 Positive Breast Carcinoma | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC... and other conditionsUnited States
-
Merck Sharp & Dohme LLCRecruitingMetastatic Castration-Resistant Prostate CancerUnited States, Austria, Canada, France, Germany, Ireland, Italy, Mexico, Netherlands, New Zealand, Poland, Russian Federation, Sweden, Taiwan, Turkey, Ukraine, United Kingdom, Spain, Finland, Australia, Denmark
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)RecruitingStage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | HER2/Neu Negative | Estrogen Receptor and/or Progesterone Receptor PositiveUnited States
-
Mohamed Sayed AbdelhafezRecruiting
-
Heilongjiang University of Chinese MedicineRecruitingThreatened MiscarriageChina
-
The George Washington University Biostatistics...Eunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingShort Cervical LengthUnited States
-
Wake Forest University Health SciencesSidney Kimmel Comprehensive Cancer Center at Johns HopkinsRecruitingMetastatic Breast Cancer | Leptomeningeal DiseaseUnited States
-
University of VirginiaEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingHyperandrogenism | PubertyUnited States
-
University of VirginiaEunice Kennedy Shriver National Institute of Child Health and Human Development...RecruitingPolycystic Ovary Syndrome | Hyperandrogenism | Normal PubertyUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI)RecruitingHematologic MalignanciesUnited States
-
University of VirginiaNational Institutes of Health (NIH)RecruitingHyperandrogenism | PubertyUnited States
-
National Institute of Mental Health (NIMH)Recruiting
-
Regeneron PharmaceuticalsBayerActive, not recruitingType 2 Diabetes Mellitus | Diabetic Macular Edema | Type 1 Diabetes MellitusUnited States, Puerto Rico, Japan, United Kingdom, Canada, Czechia, Germany, Hungary
-
CRG UZ BrusselCompletedInfertility, Female | Frozen Embryo Transfer | Hormone Replacement Therapy | DydrogesteroneBelgium
-
Centre Oscar LambretCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEdema | Erythema | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Recurrent Inflammatory Breast Carcinoma | Stage IV Inflammatory Breast Carcinoma | Peau d'OrangeUnited States
-
Thomas Jefferson UniversityNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 and other conditionsUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingAnatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC... and other conditionsUnited States
-
University Hospital, GhentActive, not recruiting
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedAnatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditionsUnited States
-
Ottawa Hospital Research InstituteThe Ottawa Hospital Academic Medical Association; Network of Canadian Emergency...Enrolling by invitation
-
Kite, A Gilead CompanyCompletedRelapsed Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B Cell Lymphoma (DLBCL) | Transformed Follicular Lymphoma (TFL) | Primary Mediastinal B-cell Lymphoma (PMBCL) | High Grade B-cell Lymphoma (HGBCL)United States, Netherlands, Canada, France, Germany, Israel
-
NRG OncologyNational Cancer Institute (NCI)Active, not recruitingStage IIIA Breast Cancer | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIC Breast Cancer | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast Carcinoma | Breast AdenocarcinomaUnited States, Canada
-
Indiana UniversityAmerican Heart Association; Purdue UniversityCompletedLong QT Syndrome | Abnormalities, Drug-InducedUnited States
-
Chinese Academy of Medical Sciences, Fuwai HospitalEnrolling by invitationCardiac Surgery PatientsChina
-
San Carlo Public Hospital, Potenza, ItalyCompletedAutoimmune Diseases | InfertilityItaly
-
National Cancer Institute (NCI)Active, not recruitingRecurrent Breast Carcinoma | Triple-Negative Breast Carcinoma | HER2-Negative Breast Carcinoma | Bilateral Breast Carcinoma | Localized Breast CarcinomaUnited States
-
University of California, DavisNational Institutes of Health (NIH); National Institute on Aging (NIA)Active, not recruitingVitamin D Deficiency | Cognitive DeclineUnited States
-
Saskatchewan Health Authority - Regina AreaUniversity of SaskatchewanTerminatedDysmenorrhea | Abnormal Uterine BleedingCanada
-
National Cancer Institute (NCI)NRG OncologyActive, not recruitingChemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerRecurrent Breast Carcinoma | HER2/Neu Positive | Progesterone Receptor Positive | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7United States, Canada, Puerto Rico, Ireland
-
Fundació Institut de Recerca de l'Hospital de la...TerminatedTreatment Side Effects | Leiomyoma, Uterine | Liver InjurySpain
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Recurrent Uterine Corpus Carcinoma | Endometrial Adenocarcinoma | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast... and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingHER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Stage IV Breast Cancer AJCC v6 and v7United States
-
Northwestern UniversityCompleted
-
IRCCS San RaffaeleCompleted
-
Copenhagen University Hospital at HerlevCopenhagen University Hospital, HvidovreActive, not recruiting
-
AC Camargo Cancer CenterH. Lee Moffitt Cancer Center and Research InstituteCompletedNeuroendocrine Tumors | Estrogen Receptor Positive Tumor | Progesterone Receptor Positive TumorUnited States, Brazil
-
University Medical Center GroningenThe Netherlands Cancer InstituteCompletedBreast Cancer FemaleNetherlands
-
Memorial Sloan Kettering Cancer CenterContext Therapeutics Inc.Active, not recruitingGranulosa Cell Ovarian Cancer | Low Grade Serous Ovarian/ Primary Peritoneal Cancer | Endometrioid Endometrial CancerUnited States
-
Centre Hospitalier Universitaire de NīmesCompleted
-
PfizerAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast CancerUnited States, Spain, Belgium, Canada, Italy, Ireland, United Kingdom
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingEstrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States